Clinical Trials Directory

Trials / Completed

CompletedNCT00160758

Physical Characteristics of Retrieved Massive Allografts

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
University of Florida · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This purpose of this study is to measure the strength of tissue allografts that have been in the body various lengths of time.

Detailed description

Allograft bone is the primary source of graft material for large skeletal defects resulting from trauma, disease, oncological resection, or reconstruction of failed total joint arthroplasties. The physical characteristics of such grafts after various intervals of remodeling and incorporation in vivo have never been studied. The purpose of this study is to obtain tissue from allografts retrieved at autopsy, at amputation for oncological complications and from patients undergoing revision procedures for failed allograft transplantation. We will evaluate the mechanical properties, histomorphometric indices and presence of microfractures. Our hypotheses are: * histomorphometric parameters of porosity and microfracture density will predict allograft strength, * microfracture density will be correlated with time in vivo and allograft strength, * the rate of host-allograft nonunion and fracture will correlate with radiation therapy and chemotherapy. The retrieved tissue will be processed using standard undecalcified histology and quantitatively assessed for degree of incorporation, allograft porosity, and microfracture density. The biomechanical characteristics of the bulk allograft and allograft-host junction will be quantified and compared to allograft bone prior to transplantation.

Conditions

Interventions

TypeNameDescription
PROCEDUREretrieve massive allograftAllograft constructs removed because of infection or cancer complications will be retained for biomechanical testing

Timeline

Start date
1999-12-01
Primary completion
2009-09-01
Completion
2009-09-01
First posted
2005-09-12
Last updated
2012-10-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00160758. Inclusion in this directory is not an endorsement.